AI summary · may contain errors
Neoadjuvant chemotherapy with interval debulking surgery (NACT-IDS) reduces unadjusted 30-day perioperative mortality versus primary debulking surgery (PDS) in women aged ≥70 with FIGO IIIC/IV epithelial ovarian cancer (RR=0.20).
- Open access
